Borosil Scientific Ltd.
Borosil Scientific Ltd. Fundamental Analysis
Borosil Scientific Ltd. (BOROSCI.NS) shows weak financial fundamentals with a PE ratio of 57.08, profit margin of 3.55%, and ROE of 3.97%. The company generates $4.5B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 64.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze BOROSCI.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakBOROSCI.NS struggles to generate sufficient returns from assets.
Valuation Score
ModerateBOROSCI.NS shows balanced valuation metrics.
Growth Score
ModerateBOROSCI.NS shows steady but slowing expansion.
Financial Health Score
ExcellentBOROSCI.NS maintains a strong and stable balance sheet.
Profitability Score
WeakBOROSCI.NS struggles to sustain strong margins.
Key Financial Metrics
Is BOROSCI.NS Expensive or Cheap?
P/E Ratio
BOROSCI.NS trades at 57.08 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, BOROSCI.NS's PEG of 1.48 indicates fair valuation.
Price to Book
The market values Borosil Scientific Ltd. at 2.27 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 19.21 times EBITDA. This signals the market has high growth expectations.
How Well Does BOROSCI.NS Make Money?
Net Profit Margin
For every $100 in sales, Borosil Scientific Ltd. keeps $3.55 as profit after all expenses.
Operating Margin
Core operations generate 6.20 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $3.97 in profit for every $100 of shareholder equity.
ROA
Borosil Scientific Ltd. generates $3.20 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Borosil Scientific Ltd. generates strong operating cash flow of $1.23B, reflecting robust business health.
Free Cash Flow
Borosil Scientific Ltd. generates strong free cash flow of $1.04B, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $11.74 in free cash annually.
FCF Yield
BOROSCI.NS converts 11.38% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
57.08
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
1.48
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.27
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.03
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.02
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.69
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.04
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.07
vs 25 benchmark
How BOROSCI.NS Stacks Against Its Sector Peers
| Metric | BOROSCI.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 57.08 | 23.86 | Worse (Expensive) |
| ROE | 3.97% | 1107.00% | Weak |
| Net Margin | 3.55% | -612.00% (disorted) | Weak |
| Debt/Equity | 0.02 | 0.72 | Strong (Low Leverage) |
| Current Ratio | 3.69 | 2.66 | Strong Liquidity |
| ROA | 3.20% | -30467.00% (disorted) | Weak |
BOROSCI.NS outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Borosil Scientific Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary
EPS CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary
FCF CAGR
N/A
Industry Style: Cyclical, Growth, Discretionary